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Background: Mecp2 null mice model Rett syndrome (RTT) a human neurological disorder affecting females after
apparent normal pre- and peri-natal developmental periods. Neuroanatomical studies in cerebral cortex of RTT mouse
models revealed delayed maturation of neuronal morphology and autonomous as well as non-cell autonomous
reduction in dendritic complexity of postnatal cortical neurons. However, both morphometric parameters and high-
resolution expression profile of cortical neurons at embryonic developmental stage have not yet been studied. Here
we address these topics by using embryonic neuronal primary cultures from Mecp2 loss of function mouse model.
Results: We show that embryonic primary cortical neurons of Mecp2 null mice display reduced neurite complexity
possibly reflecting transcriptional changes. We used RNA-sequencing coupled with a bioinformatics comparative
approach to identify and remove the contribution of variable and hard to quantify non-neuronal brain cells present in
our in vitro cell cultures.
Conclusions: Our results support the need to investigate both Mecp2 morphological as well as molecular effect in
neurons since prenatal developmental stage, long time before onset of Rett symptoms.
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Mecp2 encodes a methylated DNA-binding protein
and is the causative gene of Rett syndrome [1] (RTT,
MIM #312750) a progressive neurodevelopmental disorder
affecting 1:10,000 females worldwide [2]. Patients are ap-
parently healthy during the first 6–18 months of life, then
the disorder causes mental retardation, deceleration of head
growth, seizures, motor dysfunction, hand stereotypies to-
gether with many other disabling symptoms [3]. Mecp2 is* Correspondence: marcella.vacca@igb.cnr.it; maurizio.desposito@igb.cnr.it
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and B [4, 5]. In the brain these isoforms are developmen-
tally and regionally regulated, with Mecp2B (also known as
Mecp2α or Mecp2_e1) more abundant in adulthood. Both
in humans and mice the delayed onset of RTT symptoms is
in accordance with the postnatal increase of the Mecp2B
protein [6].
Neuronal morphology plays a significant role in deter-
mining how neurons function and communicate. Specif-
ically, it affects the ability of neurons to receive inputs
from other cells and contributes to propagation of action
potentials. The morphology of neurites also affects on
how information is processed by the brain [7, 8]. Likeis distributed under the terms of the Creative Commons Attribution 4.0
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neuropathology of RTT reveals an increase in neural dens-
ity due to decrease in cell size, together with reduced
neurite length and branching in post mortem brains, as
well as in Mecp2-loss of function mutant mice (Mecp2-
null). Delayed development of neuronal morphological
features and maintenance of functional networks [10] in
Mecp2-null mice suggest that MeCP2 impacts neuronal
maturation [11].
More recent studies have shown that RTT is not exclu-
sively a neuronal disease. Despite the low level of MeCP2
expression in astroglia, oligodendroglia and microglia
[12, 13], conditionally Mecp2 loss in brain non-neuronal
cells detrimentally influences dendritic integrity, synapses
and protein expression in neurons [12, 14, 15].
Availability of many RTT mouse models [16] contributed
to disentangle MeCP2 functions and demonstrate that
many RTT symptoms can be reverted by postnatal re-
activation of MeCP2 expression [17].
Initially described as a transcriptional silencer through
the binding to methylated promoters and histone dea-
cethylases recruitment, extensive studies in mouse models
have depicted MeCP2 as a multifunctional protein able to
activate gene expression, model nuclear architecture, and
regulate alternative splicing and translation [18, 19]. In
particular, the precise role of MeCP2 as a transcription
modulator is still under investigation. Expression profiling
of whole brain homogenates from Mecp2 null mice and
postmortem brains from RTT patients, revealed only sub-
tle differences. Most productive efforts to identify MeCP2
regulated-targets took into account the problem of brain
heterogeneity, in terms of regionality and cellularity, as a
dilution factor which leads to underestimate the actual
number of deregulated genes [20].
Studies conducted till this date, only evaluate post-natal
transcriptional profiling as well as neuronal morphological
parameters in RTT mouse models. Current hypothesis
claims that key embryonic and perinatal developmental
steps are not altered until presymptomatic stage (3–5 weeks
inMecp2 null male mice). A candidate gene approach study
has shown that expression of important proteins for neur-
onal maturation (i.e. ID1 and ID2, inhibitor of differenti-
ation) is impaired at embryonic day 15 (E15) in the cerebral
cortex of Mecp2 null male mice, transiently (ID2) or with a
long-lasting effect (ID1) over postnatal stages [21]. Fur-
thermore, MeCP2 has been shown to promote hetero-
chromatin reorganization during neural differentiation
of embryonic stem cells and in mouse primary cortical
neurons [22, 23]. In turn, chromatin organization changes
are essential for neuronal development, as they impact on
gene expression.
In light of these findings, in this study we investigate
the effects of Mecp2 loss of functions in earlier develop-
mental stages than those analysed so far. By performingmorphological analyses of primary embryonic cortical
neurons dissected from Mecp2 null mouse brains we
show reduced neuritic arborization due to Mecp2 loss of
function. We profiled embryonic wild type (WT) and
Mecp2-/Y (null) gene expression using RNA-sequencing
assays. The availability of cell-type specific datasets, allowed
us to use bioinformatics methods to isolate neuron
enriched deregulated genes affected by MeCP2 deficiency.
Results from our study suggest a role of non-neuronal brain
cells variability for reproducibility and validity of gene
expression profiling readouts.
Results
Mecp2 deficiency impairs primary branching of
embryonic cortical neurons
We examined primary cultures of neurons dissected
from E15 cerebral cortices of Mecp2 null embryos
(Mecp2tm1.1Bird/J strain) to investigate whether changes
in neuronal morphology already occur during early brain
development of RTT mouse models. Since Mecp2 starts to
be expressed in cortical layers at E14.5 [24] mostly in early
neuronal committed cells [6], we chose this stage to
dissect cortices of Mecp2 null and WT littermates. We
considered embryonic neuronal primary cultures a use-
ful tool to address our topic, as considerable informa-
tion has been gathered on their neuronal development
and maturation [25].
Primary cultures are often heterogeneous and require
characterization of their cell types (neurons versus non-
neuronal cells, i.e. glia) and neuronal sub-types. These
latter may be identified through neurotransmitter synthe-
sized- and/or region-specific markers. The phenotype of
our cells was investigated by immunofluorescence ex-
periments performed with cell-type specific antibodies.
Cells were labeled with anti- β-tubulin-III (Tuj1, neuronal
marker), GABAergic neurons with anti-GABA (γ- amino-
butyric acid) and astrocytes with anti-GFAP (glial fibrillary
acidic protein). More than 90 % of cortical cells in WT
and Mecp2 null mouse cultures were neurons, as judged
by counting the Tuj1 positive cells counterstained with
the nuclear marker DAPI (Fig. 1). The percentage of
GABAergic positive neurons over Tuj1 positive cell
was about 30–35 %, whereas GFAP-positive cells were
rare (about 1 % of DAPI stained nuclei). An additional
figure file shows this in more detail [see Additional file 1].
Subsequently to characterization, cortical cells were
stained with Tuj1 antibody and morphometrically analyzed.
We will refer to neurites because cells were in vitro cul-
tured for only three days, not enough time to distinguish
axons from dendrites. The length of the neurites was esti-
mated by measuring the distance from the cell soma to the
end of the primary neurites (neurites that originate directly
from soma). Neurite branching was estimated by Sholl ana-
lysis, one of the most commonly used methods to quantify
Fig. 1 Immunocytochemical staining of cortical primary cultures
derived from WT and Mecp2 null mouse E15 embryos. Cortical
neurons were immunostained using an anti- Tuj1 antibody (red) and
representative images are shown. Cell bodies were counterstained
with the nuclear marker DAPI (blue). Magnification: 20x; Leica
DMI6000 B inverted microscope
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of neurites does not differ between WT and Mecp2 null
neuronal cultures (Fig. 2a). On the contrary, total branching
and primary branching (i.e. the number of secondary
neurite portion/fragment growing from the main neurite
extension) are significantly lower in Mecp2 null neurons
compared to age-matched WTcontrol (Fig. 2b).Fig. 2 Morphometrical analysis of cortical primary cultures from WT and M
compare morphological parameters between WT and Mecp2 null conditi
antibody (ImageJ software). The image on the right shows a representati
the nuclear marker DAPI (blue). The operator manually drew the dashed
neurite in order to measure neurite length. b Total and primary branchin
series of consecutive concentric circles centered on the soma of the neu
on the right side). The bars represent means ± SEM from randomly selectMecp2 deficiency impairs gene expression of embryonic
cortical cells
Primary cell cultures from WT and Mecp2 null mice
were profiled by RNA-sequencing to obtain a high-
resolution dataset and search for cortical genes pos-
sibly affected by MeCP2 loss during early mouse
development.
As Mecp2 is an X-linked gene, we collected only male
embryos to avoid the confounding effect of X chromo-
some inactivation typical of females on gene expression
profiles. The inbred C57Bl/6 J strain was used to minimize
genetic background influence. In order to minimize inter-
individual variability, RNA isolated from cells of single
embryos was pooled accordingly to Mecp2-genotypes in
three samples/genotype (see Methods) and RNA from
each sample was sequenced.
We obtained 30 million of reads per sample with quality
scores higher than Q20, mapping on average 96 % of them
to Mus musculus reference genome sequence (GRCm38).
A hierarchical clusterization based on correlation was per-
formed to check the quality of the samples (an additional
figure file shows this in more detail [see Additional file 2]).
One null and one WT samples did not cluster properly
(data not shown), thus they were excluded from further
analysis.ecp2 null mouse E15 embryos. Neuronal primary cultures were used to
on. a Neurite length was measured on cells stained with anti-Tuj1
ve Tuj1 immunostaining (red) of cortical neurons counterstained with
yellow line from the soma (yellow circle) to the end of the primary
g was evaluated by Sholl analysis. Its internal algorithm creates a
ron and counts the number of neurites crossing these circles (drawn
ed fields for each cell culture condition (n = 8). * p < 0.05
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WT samples (RPKM values: 10.21 and 9.22 for WT2 and
WT3 respectively) suggesting similar levels of expression.
In null samples, few Mecp2 specific reads (RPKM values:
0.90 and 0.84 for N2 and N3, respectively) mapped ex-
clusively downstream to the deleted part of the gene. In
addition, we found intergenic reads spanning the 3 kb
genomic region from Mecp2 3′UTR to Irak1 locus (an
additional figure file shows this in more detail [see
Additional file 3, left panel]). The counts per million
(CPM) of the reads mapping in this region was 5.5 and
0.04 for Mecp2-/Y and WT samples, respectively. The
observed difference was found to be statistically significant
after Welch Two Sample t-test (p <0.05) and transcription
of this region was confirmed by RT-PCR with two differ-
ent sets of primers ([see Additional file 3, right panel]).
As for the overall transcripts data set, by quantitative
comparison and using a q-value (FDR) ≤0.05 we find 490
differentially expressed (DE) genes in E15 cortical neurons
of null mice versus WT littermates, with 394 up-regulated
(80 %) and 96 down-regulated (20 %) genes. DE genes clus-
ter in 7 classes (Fig. 3) according to their expression pro-
files and their average fold-change (FC). Down-regulated
genes show a mean FC of −0.93, whereas most part of
up-regulated genes shows a mean FC of 1.22. Among
up- regulated genes belonging to Cluster_3, we find
GFAP (ENSMUSG00000020932) commonly referred to
as an astrocyte marker. Even if GFAP has been already
reported as a Mecp2-target in RTT patients [27] and in
Mecp2-knock down rat model [28] this finding was not
fully expected. Indeed GFAP was not found deregulated
in primary astrocyte cultures prepared from postnatal
day 1 cerebral cortex of the same null mouse strain [29]
we used in this study. In fact, transient upregulation of
GFAP in Mecp2-deficient cells seems to be female specific
at least in amygdala and hypothalamus [28], whereas it
increases in the hypothalamus of a male transgenicFig. 3 Percentage distribution of differentially expressed (DE) genes
across clusters of FC average. K-Means clustering applying Pearson
correlation as distance metric identifies 7 clusters based on the mean
fold change of the 490 DE genes. Cluster_2 includes all down-regulated
genes (green). Up-regulated genes (red) are enriched in Cluster_3 and
broadly distributed in Cluster_1 and Clusters_ 4–7mouse overexpressing MeCP2 under its endogenous
promoter [30].
Aldh1L1 (ENSMUSG00000030088), another gene map-
ping to the same FC based cluster of GFAP (cluster_3), is
up- regulated as well in null samples versus controls.
Aldh1L1 strongly labels many more astrocytes than GFAP
[31]. This finding, together with the fact that primary
cells were 90 % composed of neurons (see previous re-
sults above), suggested us to verify whether the expres-
sion of other non-neuronal markers occurred across
profiled samples. Microglia and oligodendrocyte markers
(CD11B-ENSMUSG00000030786 and NG2/CC1- ENS
MUSG00000015478/ENSMUSG00000005871, respect-
ively) are indeed expressed in our in vitro cellular system,
even if their expression ranged from very low to slightly
low levels (not shown).
Bioinformatics cell sorting reveals neural differentially
expressed genes at embryonic developmental stage
We next wanted to verify the hypothesis that some of
the differentially expressed genes that we identified could
be of non-neuronal origin. To do this we bioinformatically
sorted the cells using available gene expression microarray
data from the main central nervous system (CNS) neural
cell types [31]. We map the 490 differentially expressed
genes resulted from RNA- sequencing across three differ-
ent neural cell types. Figure 4 shows that 34 % of DE genes
found in this study may be collected specifically under the
astrocyte-signature (167/490), 9 % (45/490) under oligo-
dendrocyte- cell type, while 14 % (71/490) of genes may
be enriched in neuronal cells. We classify the remaining
196 DE genes (40 %) as unmapped. Most of these latter
genes (168/196, see Additional file 4) were present on the
GeneChip microarray (GSE9566) used in Cahoy’s study
[31] but probably they have not any cell type specificity.
Moreover, as the expression of microglia marker-CD11B/
Itgam was found among the 196 unmapped genes, we
compared them to the recently reported microglia sen-
some [32], without finding yet any overlapping gene.
Differentially expressed genes with astrocyte transcriptional
signature
Firstly, we compared the list of the 167 genes enriched
in astrocytes with those specifically deregulated in post-
natal primary cultures of Mecp2-/Y astrocytes [29]. Only
3 genes overlap with our astrocyte-enriched dataset:
Gabrg1 (ENSMUSG00000001260), encoding GABA-A
receptor gamma 1 concordantly deregulated in both
datasets; Aldoc (ENSMUSG00000017390) and Fgfbp3
(ENSMUSG00000047632) that are discordant with results
of Yasui ([see Additional file 5]). This finding, together with
the fact that two astrocyte markers such as GFAP and
Aldh1L1 (see above) have been found both up-regulated in
our Mecp2-null derived primary cultures versus controls,
Fig. 4 Distribution of the 490 differentially expressed genes in neural cells. The Jvenn diagram compares the 490 DE genes of this study (DE_NvsWT)
with genes representing the transcriptional signature of neurons, oligodendrocytes and astrocytes (obtained from [31]). Focusing on genes specifically
enriched in each cell-type we find: 71 neuronal genes, 167 astrocytes genes, 45 oligodendrocytes genes. Unmapped genes are 196, whereas 9 genes
are shared between two cell- types
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Aldh1L1+ cells (even if rare) were originally present in the
null compared to the WT cultures from which RNA for
sequencing was isolated.
Differentially expressed genes with oligodendrocyte
transcriptional signature
Among the 490 DE genes only 9 % are enriched in oligo-
dendrocytes (Fig. 4). We find comparable expression of
NG2, a marker of oligodendrocyte precursor cells, and
CC1, a marker of mature oligodendrocytes. These markers
are not differentially expressed with the respect to the
genotype of samples (see Additional file 5).
According to Gene Ontology (GO) analysis (An add-
itional composite figure file shows this in more detail [see
Additional file 6A]) the most significantly represented
biological processes are those related to ensheathment
of neurons (especially myelination) and regulation ofaction potential (GO: 0042552 and 0019228, respectively
with p-value ≤ 0.05). Given that the transcriptome dataset
[31] profiles cells in postnatal mouse, GO outcomes would
have been biased towards biological process more active
in postnatal stages, as myelination does.
Nonetheless, GO together with Panther analysis (see
Additional file 6B) give us interesting directions of inves-
tigation to be tested, as the most enriched annotations
in this category of genes are related to protein families
involved in oligodendrocytes differentiation, such as
Olig 1 and 2 [33], CD82 [34] and CD9 [35], or to lipid
synthesis ([see Additional file 6A]), such as ELOVL7
[36] whose expression increases in null cells here se-
quenced ([see Additional file 5]). To be noticed, aberrant
oligodendrocytes maturation could affect neuronal-non
neuronal cells interactions [15] as reported for astroglia.
Furthermore, among the 45 deregulated genes within
oligodendrocyte- cell type no matches have been found in
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genes [37] suggesting that their expression level might be
constant during brain development.
Differentially expressed genes with unrecognized
transcriptional signature
Functional annotation of the 196 DE genes not mapped
to neurons or glial cells shows that they are significantly
enriched in biological process like the Tumor necrosis
factor (TNF)-mediated signaling pathway (An additional
figure file shows this in more detail [see Additional file 7).
In response to numerous stimuli, TNF-pathway triggers
downstream effects related to cell viability, gene transcrip-
tion, ion homeostasis and synaptic plasticity. This pathway
as well as activated microglia are key mediators of neuroin-
flammation and may contribute to neuronal dysfunction.
This functional outcome may have important molecular
implications on the neuronal morphological phenotype
here described, as it has been shown that postnatal Mecp2
null mouse microglia detrimentally affects dendrites and
synapses by releasing an excess of glutamate [14].
In addition, as perturbation of embryonic microglial
activity impairs normal assembling of cortical networks
[38] there could be a causal relationship between
MeCP2-deficient microglia and forebrain connectivity
even during embryonic development.
The microglial marker CD11B indeed maps to this cat-
egory but it results to be up-regulated in our Mecp2 null
cell cultures versus WT control, possibly indicating a dif-
ferent distribution of CD11B+ cells across profiled sam-
ples, as another report indicates that CD11B is not
altered by Mecp2 deficiency [14].
Differentially expressed genes with neuronal transcriptional
signature
Of the 71 genes assigned to neuronal cells, forty-three
genes (60 %) are more expressed in Mecp2 null cells
than in WT while the remaining twenty-seven genes
(40 %) are down-regulated ([see Additional file 5]).
Before further characterizing these genes we checked
whether neuronal and GABAergic markers were equally
expressed across samples. The overall number of neurons
does not differ between WT and null samples, as previ-
ously shown by Tuj1-immunofluorescence staining (see
above) and then confirmed at transcriptional level by
RNA-sequencing (β-tubulin-III- ENSMUSG00000072235
RPKM values in WT samples are 1202.42, and 1081.06, re-
spectively; in null samples 1043.82 and 1114.27, respect-
ively). Similarly, there are no differences in expression
level of: a) GABAergic marker-transcripts, such as GABA
synthesis enzyme GAD2 (ENSMUSG00000026787, RPKM
values in WT samples are 8.30 and 6.46, respectively;
in null samples 6.51 and 6.58, respectively); b) GAD1
(ENSMUSG00000070880); c) genes encoding the GABAtransporters, such as Slc32a1 and Slc6a1 together with
Dlx1 and Arx [39] ([see Additional file 5]).
Assuming homogeneity of samples, the list of DE genes
carrying a neuronal transcriptional signature was then an-
alyzed, to search for functional categories more enriched
and potentially targeted by Mecp2 loss. Functional clus-
tering (Fig. 5) shows 7 significantly represented clusters
(p-value < 0.05), with three molecular function terms
(clusters A, C and D) and four biological process annota-
tions (clusters B, E-G). Interestingly, the major functional
themes assigned are specifically related to neuron specific
features, such as neurogenesis and cell differentiation
(cluster E) together with neuronal activities. Indeed, ion
binding (cluster A), transport (cluster B) and channel
activity (Cluster C, D and F) altogether sustain synaptic
transmission. Among genes listed in these functional
clusters, some contribute to shape neuronal morphology,
such as Mef2C and Tiam1 (also identified in [30]). An-
other interesting gene found in these clusters is GDA
encoding guanine deaminase, a protein involved in
microtubule assembling [40] and regulation of dendrites
number [41]. To further validate the GO and functional
annotation results, we carried out enrichments analysis of
each GO and functional terms separately for the given list
of neuronal specific genes. We obtained enriched GO and
functional terms along with multiple test corrected p-
values (An additional table file shows this in more detail
[see Additional file 8]). Together with DAVID annotation,
we carried out GO annotation analysis through AmiGO 2,
obtaining significant GO terms using Bonferroni correc-
tion method (p-value < 0.05). The results (see Additional
file 8) confirm the biological inference for the neuronal
specific genes obtained by DAVID analysis.
To understand whether the neuronal genes mis-
regulation we found at embryonic stage is conserved
throughout development, we compared our data with
a number of gene expression studies profiling various
brain regions of postnatal Mecp2 mutant brain. To
avoid any mouse background confounding effects, we
focused our interest in regions dissected from the
same Mecp2 null mouse strain [30, 42] analyzed in this
study. We find that the highest rate of sharing is
achieved with hypothalamic genes: twenty-seven out
of seventy genes (excluding Mecp2) are differentially
expressed in postnatal hypothalamus of Mecp2 null
mice [30] with 12 genes (44 %) deregulated in the same
direction ([see Additional file 5]). Only two genes are con-
cordantly shared with cerebellum of Mecp2 null mice,
with Pls3 (ENSMUSG00000016382) gene also present in
the hypothalamus list ([see Additional file 5]). The pair-
wise comparison of the 71 neuronal DE genes with those
published by Zhao and colleagues [43] in symptomatic
P60 (postnatal day 60) Mecp2 null mice (Bird strain) re-
vealed only 4 genes in common (see Additional file 5).
Fig. 5 Functional annotation clustering of neuronal specific differentially expressed genes. Using Functional annotation clustering algorithm
in-built in DAVID web resource, seven functional annotation clusters based on GO terms (biological process, molecular function and cellular
components) were obtained within neuronal specific differentially expressed genes. Each cluster is significantly enriched with enrichment
score cut-off value >1. Within each cluster, all the related gene ontological terms are also separately enriched for the given neuronal specific
gene with Ease score value (see Methods) cut-off ≤ 0.05. Note that the most enriched biological process GO terms fall within clusters E and F
and are related to specific neuronal functions. No cellular compartment cluster was sufficiently enriched
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tioned are also shared between the two datasets, uncover-
ing specific functions of MeCP2 regulated genes during
development.
Screening the cerebral cortex dataset of healthy mice
[37] we find 30 genes ([see Additional file 5]) merging
with our neuronal enriched dataset. Notably, 90 % of
them become more highly expressed in adult cortex dur-
ing mouse development, including 7/8 deregulated genes
concordant with hypothalamic findings.
Finally, we find that 50 % of neuronal enriched up-
regulated genes (22/44, data not shown) are long genes
(around or more than 100 kb) as already reported for
MeCP2-repressed genes [20, 44].
Discussion
Neuroanatomical studies in cerebral cortex of Mecp2 null
mice showed delayed maturation of neuronal morphology
and autonomous as well as non-cell autonomous reduc-
tion of dendritic complexity of postnatal cortical neurons.In addition, abnormal cell body size and density of both
glutamatergic [45–47] and GABAergic neurons [48] has
been reported for a RTT mouse model [48] as well as for
inhibitory neurons differentiated from human embryonic
stem cells lackingMecp2 [49].
In this study, we describe effects of Mecp2 loss of
function both on the morphology and transcription pro-
file of the embryonic neocortical neurons. Interestingly,
we find a reduced neurite branching in Mecp2 null neu-
rons, whereas neurites length is not affected. Similar re-
sults have been recently described in inhibitory neurons
differentiated from human embryonic stem cells lacking
Mecp2 [49]. In addition, we identify a neuronal subset of
embryonic deregulated genes that are highly expressed
in mouse adult cortex, possibly indicating that some
subtle embryonic defects will be functionally amplified
later in postnatal life when clinical RTT symptoms be-
come evident. The findings in our study further support
the hypothesis that Mecp2 has a role in structural plasti-
city of cortical neurons and highlight the effects on the
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recently reported that Mecp2 deficient mice display re-
gional- and age-dependent variations in the GABA path-
way and, to a lesser extent, in the glutamate pathway [50].
Focusing on functional annotations significantly enriched
in neuronal cells here profiled, we achieved additional
as well as interesting results: MeCP2 deficiency should
impair the same biological process even across different
brain areas and developmental stages, as suggested by
the overlapping of Gene Ontology terms with those de-
scribed for striatal deregulated genes of postnatal Mecp2
null mice [43].
However, it would be interesting to measure in our
cellular system the impact of non-neuronal cells on the
transcription of neuronal genes. Indeed, the deregulated
genes due to the Mecp2 loss only in the striatal GABAergic
neurons partially overlap with those impaired by a constitu-
tiveMecp2 loss [43].
Our bioinformatics approach on the list of differen-
tially expressed genes in primary cultures from Mecp2
null and WT cortices has another important outcome:
on one hand allows to focus on genes with a neuron
transcriptional signature, while on the other identifies
non-neuronal enriched genes contribution to the list. Over-
all findings from non-neuronal cortical cells may suffer
from inter- individual variability and chance to survive in
serum-free culturing medium. Prior RNA-sequencing,
pooling of samples (merely based on genotype and gender
of embryos) may have masked such variability, giving rise
only to partial conclusions ofMecp2 loss of function effects.
The simultaneous presence in our cultures of different
neural populations allowed us to preserve cell-cell interac-
tions between neurons and non-neuronal cells. This is a
fundamental aspect in molecular and morphological
studies of Mecp2 null cells, as neuron-glia and -micro-
glia interactions have emerged as a crucial point to
control RTT progression and for some of them to reverse
symptoms.
There is an extensive reorganization of mouse transcrip-
tome between embryonic and postnatal developmental
stages [37, 51]. Moreover, gene expression programs are
highly divergent across cell types [52]. Likely, not overlap-
ping results of downstream effectors of Mecp2 deficiency
can be also affected by the specific developmental window
of profiling. In addition, it has been shown that sorting
methods to profile specific cell types can themselves
produce in some cases not comparable results [53]. Despite
this, a small subset of deregulated neuronal genes here
identified has already been described in a previous study
[30] at a postnatal stage and in a different brain region
(hypothalamus). We speculate that Mecp2 loss may impact
transcripts abundance of those genes in a space-temporal
independent ways, starting from mid-gestation period.
Interestingly, at E15 when those genes are deregulatedin the cortex, MeCP2 protein is not detectable in hypo-
thalamus [24].
Most part of neuron-enriched deregulated genes here
found are up-regulated, whereas in previous studies most
part of Mecp2 deregulated genes are repressed. This dis-
crepancy may be likely linked to different developmental
stages analysed but also to the technology utilized, given
that we were able to measure even very low expressed
genes (see Fig. 3). However the rate of up-regulated genes
here found is consistent with that reported by Sugino [20]
based on cell type specific approach. Moreover, concor-
dantly to Sugino et al. [20] and Gabel and et al. [44] we
also find that genes up-regulated by Mecp2 loss are biased
toward long genes.
In addition, RNA-sequencing permitted us to confirm
that Irak1 deregulation is causally linked to genetic
structural manipulation of mouse Mecp2 locus, rather
than to functional loss of Mecp2. Indeed Irak1 levels
specifically increase in the Bird strain of Mecp2 null
mice lacking exons 3 and 4 [54], whereas in the Jaenisch
strain is normally expressed [55]. In all brain regions to
date profiled [30, 43, 55–57] and in this study, Irak1 is
always up-regulated. Our mapping of reads in the inter-
genic region between Mecp2 and Irak1 in null samples
may be due to spurious transcription occurring in the
absence of terminal coding part of Mecp2 gene. It is thus
reasonable to suppose that at least a subset of differen-
tially regulated genes found in this study and by others
should be considered as Irak1- dependent downstream
effects rather than Mecp2 targets. Among downstream
effectors of Irak1 signalling pathway there is NF-Kb, a
transcription factor even acting as a modulator of neur-
ite outgrowth [58]. Moreover, the virtual cell sorting we
performed assigned Irak1 to cells resembling activated
microglia, characterized by TNF-mediated signal pathway
enrichment. This finding supports an already proposed
hypothesis of a constitutive activity of signalling pathways
mediating the TNF- action, as Mecp2 null microglia
releases significantly less TNF-alpha under specific
stimulation [14]. Remarkably, our findings motivate
further studies focused on genes involved in shaping
cell morphology, whose mis-expression can lead to al-
tered formation, pruning and maintenance of neurites
and synapses. Mef2c and Tiam1, already described as
Mecp2 target genes, may be good candidates. Mef2c
negatively regulates synapses number and function
[59] and is up-regulated by Mecp2 loss (this study and
[30]. Tiam1, essential for Rac1 activation and neurite
outgrowth of cortical neurons [60], is slightly down-
regulated in the cellular system we analyzed. As Tiam1
manifests the opposite response to Mecp2 loss in post-
natal hypothalamus [30], we can suppose that Mecp2
may exert regional and/or stage specific regulation on
specific genes. On the contrary, the up-regulation of
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compensatory strategy of neuron to recover branching
defects [10], whereas the up-regulation of thyrotropin
releasing hormone (TRH)-degrading enzyme would have
a direct impact on action potential shaping of cortical
neurons.
Conclusions
To our knowledge dendritic complexity of embryonic
cortical neurons, as well as the embryonic high- reso-
lution expression profile was never examined in Mecp2
null mice. Using a very sensitive technology we were able
to profile even genes transcribed at low level, showing that
our close to pure primary neuronal cultures derived from
embryonic cortices may in fact contain low and poorly
detectable amount of non neuronal cells. The virtual a
posteriori cell sorting here described allowed also to
focus specifically on differentially expressed genes of
neuronal origin. We are confident that the cellular sys-
tem here used could be further investigated, providing
a fine characterization of neuronal subpopulation together
with non-neuronal cells.
We thus suggest that abnormal morphology and altered
expression profile of neurons may be very early phenotypes
of RTT mouse models. Furthermore, subtle embryonic de-
fects will be functionally amplified later in postnatal life,
when overt RTT phenotypes will be established.
Methods
Animals
Female Mecp2 heterozygous females [54] were purchased
from Jackson Laboratories (strain name: B6.129P2(C) −
Mecp2tm1.1Bird/J, stock number 003890). Mecp2 mutant
hemizygous males (Mecp2 -/Y, also indicated as Mecp2
null) and wild type (WT) littermates used as controls were
obtained by mating heterozygous females with WT males
(C57BL6/J background) for at least 12 generations. The
national or institutional guidelines were used for the care
and use of animals, and approval for the experiments were
obtained from the ethical committees of the Italian Minis-
try of Health and the UK Home Office.
Genomic DNA was extracted from tail tips of embryos
and immediately genotyped by polymerase chain reaction
to determine Mecp2 deletion (according to [54]) and mice
gender. The gender was determined using primers mSRY.F
5′-CCCAGCAGAATCCCAGCATGC-3′ and mSRYl.R 5′-
TCCTGTCCCACTGCAGAAGGT-3′ specific for the Y
chromosome-linked Sry gene.
Cortices from each embryo were separately dissected
from those of the other littermates.
Neuronal primary cultures
Dissociated cells were prepared by dissecting out cortices
from individual embryos at embryonic day 15 (E15). Theday of insemination (i.e. the appearance of a vaginal plug)
is designated as embryonic day 0 (E0).
Cortices were dissected under a stereoscope in sterile
conditions and placed in phosphate buffered saline (PBS)
without calcium and magnesium, supplemented with
33 mM glucose. Cells were then cultured as previously de-
scribed [61]. Briefly, the dissected areas were enzymatically
dissociated by incubation for 20 min (min) at 37 °C in a
papain solution (Warthington, 20 U/ml, Milan, Italy) in
Earle's balance salts containing 1 mM EDTA (Sigma-Al-
drich, Milan, Italy), 1 mM cysteine (Sigma-Aldrich) and
0,01 % pancreatic DNAse (Sigma-Aldrich). After addition
of 1 mg/ml of bovine serum albumin (Sigma-Aldrich) and
1 mg/ml ovomucoid (Sigma/Aldrich) the cells suspensions
were centrifuged 5 min at 800 rpm, resuspended in plating
medium and counted [62]. For the viable cell count, cell
suspension was diluted 1:1 with 0,1 % trypan blue dye
(Sigma Aldrich) and loaded into a disposable cell counting
chamber-slide. Cell concentration was determined on the
basis of the total cell count, the dilution factor and the
trypan blue dye exclusion.
Dissociated cells were plated at a density of 1 × 105/
cm2 in 2 cm2 cell cultures dishes (Corning) coated with
15 μg/ml of poly-D-lysine dissolved in water (Sigma-
Aldrich).
Cultures were grown in serum-free Neurobasal medium
(Life technologies, Milan, Italy), supplemented with B27
(Life technologies), 2 mM L-glutamine (Sigma-Aldrich),
penicillin (50U/ml, Sigma-Aldrich) and streptomycin
(50 μg/ml, Sigma-Aldrich). Cells were maintained for
3 days in vitro (DIV) at 37 °C in a humidified incubator in
presence of 5 % CO2, before experimental manipulation.
For each experimental point, cultures were prepared at
least in independent triplicates, and were repeated using
distinct culturing sessions.
Only primary cultures deriving from male embryos
(see above) were then selected for subsequent analyses.Immunocytochemistry and analysis of morphometric
parameters
For immunocytochemical analyses cultured cells were
fixed in 4 % paraformaldehyde in PBS, for 30 min at
room temperature (RT), washed three times in PBS, and
then permeabilized for 20 min in PBS containing 0,1 %
Triton-X-100 and 10 % normal goat serum (NGS). Cells
were treated with blocking solution [10 % NGS, 0,1 %
bovine serum albumine (BSA) in PBS] at RT for 1 h and
incubated with the primary antibody in antibody solu-
tion (PBS containing 0,1 % BSA) overnight at 4 °C. The
following antibodies were used at the indicated dilutions:
monoclonal antibody against neuron specific class III β-
tubulin (Tuj1, Covance, Milan, Italy) 1:500, polyclonal
rabbit antibody anti-γ-Aminobutyric acid (GABA, Sigma,
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Acidic Protein (GFAP, Dako, Z 0334) 1:450.
Cells were washed 3 times in PBS, and then incubated
for 2 h at RT with fluorescent-labeled secondary anti-
bodies (Alexa Fluor Goat anti-rabbit, and Alexa Fluor
Goat anti-mouse, Life Technologies) diluted 1:400 in
antibody solution.
Cells were then counterstained with DAPI (nuclear stain,
1:1000) for 10 min, washed with PBS and mounted with oil
mounting solution (Mowiol). As negative controls, some
cells were processed as described above, but without
primary antibody.
For morphological analyses, cells fixed and perme-
abilized as above, were incubated with the monoclonal
antibody against neuron specific class III β-tubulin (anti-
Tuj1, 1:750, Covance) and with the fluorescent-labeled
secondary antibody, both diluted in PBS containing 10 %
NGS, for 2 h at RT. After Tuj1 staining, cell-culture slides
were analyzed with a Leica microscope (Leica DM6000B)
using the software Leica Application Suite (LAS AF). Im-
ages were obtained by using a 20x objective and captured
with a HAMAMATSU Digital Camera C10600 ORCA R2.
Measurements of neurites length have been performed by
the image-processing software Image J. Images were pre-
processed to optimize illumination and contrast. The
length of the neurites was estimated by measuring the
length of a line manually drawn from the soma to the end
of the primary neurites (neurites that originate directly
from soma) using the “Measure” function of the software.
The primary branching was measured by the Image J
plugin “Sholl analysis”. Its internal algorithm creates a
series of concentric circles around the soma of the neuron
and counts the number of neurites crossing these circles.
Only clearly visible cells were analysed to prevent inaccur-
ate scoring. For morphological analyses, a total of 15 fields
for each cell-culture condition were used from at least
three independent culture wells.
A total of 300 neurites/well were traced from Tuj1
positive neurons to measure their length. The analyses
were carried out “blind” to avoid any subjective influences
during measurements.RNA isolation, sequencing and RT-PCR
Total RNA was prepared from neuronal primary cul-
tures using TRIZOL Reagent (Invitrogen) with addition
of 150 μg of RNAase-free glycogen in order to maximize
yield. RNA was then treated with RNase-free DNase
(Ambion, DNA-free kit).
To minimize inter-individual variability, equal amount
of quality checked RNAs from three individual embryos
were mixed to constitute a pooled sample. With this
procedure we obtained 3 samples/genotype with 1:1 pro-
portion between RNAs derived from each Mecp2 nullembryo (males) and those isolated from WT littermates.
Samples were labeled as WT1-3 or N1-3.
RNA libraries were constructed using the TruSeq
Stranded mRNA Sample preparation kit (Illumina), and
single-strand sequenced on Illumina Hiseq2500 platform
at the Istituto di Genomica Applicata (Udine, Italy). The
first purification step isolates the poly-A containing
mRNA molecules using poly-T oligo attached magnetic
beads. During the second elution the poly-A RNA is also
fragmented and primed for cDNA synthesis.
To verify the changes in expression of the intergenic
region between Mecp2 and Irak1 loci, RT-PCR was per-
formed on independent samples from additional animals.
For each sample 1 μg of total RNA prepared from neuronal
primary cultures was digested with DNase (Ambion, DNA-
free kit) and reverse-transcribed by random-priming using
SuperScript II first strand kit (Invitrogen). The following
mouse primers were used for PCR analysis: inter5F 5′-
GTCCCTAATGGGAGAACCGA-3′ and inter2R 5′-AGG
TGAGTGGCAATGGCTAA-3′; inter3F 5′-CCCAGCTCC
TCTCTTGAACAC-3′ and inter3R 5′-CTTTCAGCTGGC
CAAACAAGG-3′. As loading control, GAPDH primers
have been used: gapdhup 5′- TGCACCACCAACTGCTT
AGC-3′ and gapdhlw 5′-TCTTCTGGGTGGCAGTG
ATG-3′.
RNA-sequencing data analysis
Raw reads were processed with Trimmomatic [63] in
order to remove low quality nucleotides and adapters.
The minimum phred quality score for bases was set to
35 and only reads with a minimum length of 25 bp were
retained after trimming. The high quality reads were
aligned against the Mus musculus reference genome se-
quence (GRCm38) with TopHat [64] version 2.0.9. The
resulting alignment files were used as input for HTSeq-
count [65] version 0.5.4p2 together with the GRCm38
annotation file to calculate gene expression values (read
counts). Genes with very low read counts or those that
were too variable among the replicates were removed
with HTSFilter [66]. Differential expression analysis was
performed in R with the package TCC [67] in combin-
ation with edgeR [68]. The coordinates of the intergenic
region between Irak1 (ENSMUSG00000031392) and
Mecp2 (ENSMUSG00000031393) and the number of the
mapped reads in each sample were obtained with bed-
tools (v2.17.0).
Expression profiles of the differentially expressed genes
were used to perform a K-mean clustering with MeV
[69] and 7 clusters were identified by using Pearson Cor-
relation as distance metric.
Gene Ontology (GO) and functional annotation en-
richment analysis was carried out using Database for
Annotation, Visualization and Integrated Discovery
(DAVID) bioinformatics resources 6.7 (http://david.abcc.
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and Infectious diseases (NIAID), NIH. We used both
DAVID web interface as well as custom made Python
script implementing DAVID-web services in our in-house
built Transcriptator software [70].
Transcriptator helps in determining automatic and
reproducible GO and functional annotation results for
the differentially expressed list of genes derived from
transcriptomic analysis of data. Currently, DAVID pro-
vides annotation for 40 different categories. In our
computational pipeline we includes GO terms, protein-
protein interactions, protein functional domains, bio-
pathways, sequence general features and gene functional
summaries. Using DAVID web application, we exploited
functional annotation enrichment as well as functional an-
notation clustering tools to obtain clusters of differentially
expressed genes based on common functionalities. For the
GO and functional annotation enrichment, we defined a
stringent Ease score (p- value) ≤0.05 and Count ≥5, which
is basically a modified Fischer exact test p-value to exam-
ine more conservatively the enrichment situation.
For neuronal specific genes, we carried out functional
annotation clustering based on the algorithm in DAVID,
which hypothesizes that similar annotations should have
similar gene members. It integrates the Kappa statistics
to measure the degree of common genes between two
annotations and fuzzy heuristic clustering to classify groups
of similar annotations according to kappa values. In easier
terms, the higher the number of shared annotations terms,
the greater the probability that genes will be grouped
together [71, 72].
For the functional annotation clustering implemented
algorithm and utilized in DAVID web application we
selected a stringent cut-off Ease score ≤0.05 and an
enrichment score value ≥ 1. We also carried out GO
annotation analysis through AmiGO 2 (version: 2.2.0
amigo2b) with GO database release 2015-06-06. Jvenn
software was used to create Venn diagrams [73].Availability of supporting data
The datasets supporting the results of this article are in-
cluded within the article as Additional file 5.Additional files
Additional file 1: Immunocytochemical characterization of cultured
cortical cells with neuronal and glial markers. Representative images
of cortical cells dissociated from E15 WT embryos, fixed after 3 DIV and
analysed using DAPI to stain nucleus (blue), anti-Tuj1 antibody to stain
neurons (red), anti- GABA antibody to stain GABAergic neurons, anti-GFAP
to stain structural glial/astrocytic protein (green). Merged pictures show
relative proportions and localizations of neuronal and glial cells within
a particular microscopic field. Magnification: 20x; Leica DMI6000 B
inverted microscope. (PDF 3158 kb)Additional file 2: Heatmap of the expression profiles of 50 random
genes from WT and null samples. Green to red gradient has been
used to represent low and high expressed genes, respectively (FPKM values).
On the top, the dendrogram represents the result of the hierarchical
clusterization of the samples by using the euclidean distance obtained with
the expression profile of all the genes in the genome. (PDF 408 kb)
Additional file 3: Expression analysis of the genomic region from
Mecp2-3′UTR to Irak1-5′UTR in WT and Mecp2 null samples. Left
panel: From the left to the right of the figure the following elements are
shown: the coverage (grey bars) and mapped reads (red bars) for WT3,
WT2, N3 and N2 samples, the schematic structure of the 3′-end of Mecp2
and 5′-end of Irak1 (with UTRs marked as thin rectangles, exons as thick
rectangles and introns as lines). The grey lines connecting reads represent
spliced reads. The horizontal dotted box highlights the intergenic region
between Irak1 and Mecp2 to show the lack of mapped reads in the WT
samples and the presence of spliced reads connecting the two loci in
the null mutants. Right panel: RT-PCR using two set of primers spanning the
intergenic region was performed on independent WT (WT4 and 5) and null
samples (N4, 5 and 6). GAPDH transcript was used as internal control.
(PDF 129 kb)
Additional file 4: Comparison of DE genes defined as unmapped
with GeneChip microarray used in Cahoy’s study. Venn diagram
comparing Affymetrix Mouse Genome 430 2.0 Array GPL1261 probe set
(GSE9566) with unmapped genes identified in this study. Common genes
are in total 166. (PDF 26 kb)
Additional file 5: Lists of the 490 differentially expressed genes
distributed across neural cell types. DE genes found in this study have
been assigned to specific cell types accordingly to [31]. Specific cellular
markers for each cell type are shown in the related sheet at the top of
included tables. WT are wild type samples, N are Mecp2 null samples. For
unmapped genes we arbitrarily consider the microglia gene CD11B as a
marker. °Irak1 has been found always up-regulated in Mecp2 null mouse
brains (Bird strain). In the table of neuronal genes results of comparison
with dataset of 4125 developmentally regulated (E7 vs P30) genes in WT
mouse cortex [37] are shown in the last column. In particular, each shared
gene is shown with the developmental stage of enrichment reported by
Dillman and co-workers. In the table of neuronal genes, results of
comparison with 3 datasets of genes whose expression is altered in
specific Mecp2 null brain regions are provided. The hypothalamus
dataset [30] is made of genes whose expression has been found altered
both in transgenic and null mice (2582 genes, red) together with those
altered only in null mice (369 genes, blue). The concordance/discordance
labeling is referred to deregulation in null mice. In the astrocyte table results
of comparison with dataset of [29] are shown in the last column.
*Fxyd1 is an already known Mecp2-target gene found up-regulated
also in [55]. (XLSX 47 kb)
Additional file 6: (A and B):Functional annotation clustering of
oligodendrocytes specific differentially expressed genes. A) GO-based
analysis shows that most significantly enriched biological processes
(p-value≤ 0.05) of DE genes mapped to oligodendrocytes are specifically
related to this cell-type. B) Panther family-based analysis shows that most
significantly enriched terms (p-value≤ 0.05) include signaling molecules
(tetraspanin- PTHR19282) and basic helix-loop-helix transcription factor
proteins (basic helix-loop-helix protein neurogenin-related-PTHR19290) having
a documented role in oligodendrocytes differentiation. (PDF 252 kb)
Additional file 7: Functional annotation clustering of differentially
expressed unmapped genes. GO-based analysis shows that most
significantly enriched biological process (p-value ≤ 0.05) of DE unmapped
genes is an immunomodulator-mediated signaling pathway related to
broadly ranging cellular activities. (PDF 143 kb)
Additional file 8: Functional annotation analysis of neuron enriched
differentially expressed genes through DAVID and Amigo2. GO and
functional annotation enrichment analysis using DAVID (first sheet),
for the given list of neuronal specific genes. It provides enriched
functional terms with P-value and adjusted p-value (through multiple
test correction). It separately provides enriched functional annotation
terms (significant p-values) in the categories of GO terms, UP-SEQ-Features,
SP-PIR-keywords, SMART, PIR, Interpro domains and PANTHER annotations.
Vacca et al. BMC Bioinformatics 2016, 17(Suppl 2):14 Page 200 of 201The multiple test correction for these terms does not provide significant
p-values due to low number of genes in each category. GO annotation
analysis through AmiGO 2 (second sheet). Significant GO terms for biological
process, molecular functions and cellular locations are retrieved for neuronal
specific genes in our differential expressed gene list using Bonferroni
multiple test correction method, with a p-value cutoff < 0.05. (XLSX 69 kb)
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